Industry benchmark and competition - Randaemon

Randaemon compared with its industry and competitors: revenue, profit and capital percentiles. Regional ranking and position within its PKD class.

Market comparison Randaemon

Comparison with PKD sector 72.10.Z

Benchmark: use with caution

Market position (2024)

Net revenuePowyżej mediany

P10: 0Median: 124,3 tys.P90: 6,3 mln

Company: 209,4 tys. vs median: 124,3 tys.

Total assetsPowyżej mediany

P10: 416,16Median: 151,5 tys.P90: 4,9 mln

Company: 178,9 tys. vs median: 151,5 tys.

Total equityDolny decyl

P10: 0Median: 126,2 tys.P90: 2,3 mln

Company: -1,9 mln vs median: 126,2 tys.

Net profitDolny decyl

P10: -20,4 tys.Median: 849,28P90: 739,3 tys.

Company: -52,2 tys. vs median: 849,28

ROADolny decyl

P10: -21.8%Median: 0.4%P90: 39.4%

Company: -29.2% vs median: 0.4%

Asset turnoverPowyżej mediany

P10: 0.0%Median: 61.7%P90: 277.2%

Company: 117.1% vs median: 61.7%

Sector median - total assets

Company - total assets

Competitors Randaemon

Comparison with selected competing entities based on the most important financial indicators from recent years.

Add a company to compare

Type a name or KRS number to add any company to the chart and table below. Compared: 6 (5 competitors + analysed).

RandaemonAnalysedPIT-RADWARNOVO NORDISK PHARMAINSTYTUT ŁĄCZNOŚCI - PAŃSTWOWY…PAREXEL POLSKAPSE INNOWACJE

Comparison of financial results

Indicator: Revenue

One chart shows the analysed company alongside selected competitors. The view presents the most important financial indicators from recent years, letting you quickly assess scale, profitability and the company's market position.

Comparative table

A side-by-side comparison of the most important financial data for the analysed company and its peers.

Company comparison
Company	Revenue▼	Net profit	EBITDA	Assets	Equity	Net margin	ROE	Liquidity	Years	Latest year
RandaemonAnalysed WARSZAWA · Badania i rozwój	209,4 tys. zł	-52,2 tys. zł	26,4 tys. zł	178,9 tys. zł	-1,9 mln zł	-24,93%	2,77%	1,32	3	2024
PIT-RADWAR WARSZAWA · Badania i rozwój	641,8 mln zł	53,5 mln zł	128,2 mln zł	2,5 mld zł	651,0 mln zł	8,33%	8,21%	1,31	1	2024
NOVO NORDISK PHARMA WARSZAWA · Badania i rozwój	414,0 mln zł	47,4 mln zł	25,7 mln zł	217,0 mln zł	103,7 mln zł	11,44%	45,66%	2,90	6	2024
INSTYTUT ŁĄCZNOŚCI - PAŃSTWOWY INSTYTUT… WARSZAWA · Badania i rozwój	222,6 mln zł	12,4 mln zł	-	104,6 mln zł	31,1 mln zł	5,56%	39,78%	11,70	4	2024
PAREXEL POLSKA WARSZAWA · Badania i rozwój	177,5 mln zł	20,4 mln zł	-	67,2 mln zł	45,3 mln zł	11,46%	44,94%	6,51	6	2024
PSE INNOWACJE WARSZAWA · Badania i rozwój	126,1 mln zł	6,5 mln zł	8,6 mln zł	73,8 mln zł	38,0 mln zł	5,15%	17,09%	3,60	7	2025

Indicator-by-indicator comparison

Each row is a different financial indicator. The arrow and percentage value show how much each competitor exceeds or trails the analysed company.Green means the analysed company leads, red - that it falls behind.

Indicator-by-indicator comparison
Indicator	Randaemon 2024	PIT-RADWAR 2024	NOVO NORDISK PHARMA 2024	INSTYTUT ŁĄCZNOŚCI - PAŃSTW… 2024	PAREXEL POLSKA 2024	PSE INNOWACJE 2025
Revenue	209,4 tys. zł	641,8 mln zł +306385.6%	414,0 mln zł +197592.8%	222,6 mln zł +106209.3%	177,5 mln zł +84669.7%	126,1 mln zł +60129.7%
Net profit	-52,2 tys. zł	53,5 mln zł +102528.7%	47,4 mln zł +90841.0%	12,4 mln zł +23819.9%	20,4 mln zł +39087.3%	6,5 mln zł +12536.0%
EBITDA	26,4 tys. zł	128,2 mln zł +485267.4%	25,7 mln zł +97103.4%	-	-	8,6 mln zł +32497.9%
Operating profit	20,1 tys. zł	83,0 mln zł +411982.7%	25,1 mln zł +124514.6%	12,4 mln zł +61586.4%	5,9 mln zł +29053.9%	7,8 mln zł +38599.0%
Assets	178,9 tys. zł	2,5 mld zł +1376546.6%	217,0 mln zł +121180.3%	104,6 mln zł +58368.4%	67,2 mln zł +37483.9%	73,8 mln zł +41178.7%
Equity	-1,9 mln zł	651,0 mln zł +34659.0%	103,7 mln zł +5606.7%	31,1 mln zł +1752.3%	45,3 mln zł +2503.9%	38,0 mln zł +2116.2%
Net margin	-24,93%	8,33% +33.3 pp	11,44% +36.4 pp	5,56% +30.5 pp	11,46% +36.4 pp	5,15% +30.1 pp
ROE	2,77%	8,21% +5.4 pp	45,66% +42.9 pp	39,78% +37.0 pp	44,94% +42.2 pp	17,09% +14.3 pp
Current ratio	1,32	1,31 -1.0 pp	2,90 +158.4 pp	11,70 +1038.1 pp	6,51 +519.5 pp	3,60 +228.3 pp

Peer entities are picked based on activity profile (PKD), voivodeship, business scale and data availability. You can add your own peers using the search above.

Filter: PKD 72.10.Z, voivodeship mazowieckie. Data taken from /ranking and /reports.

Regional context - Randaemon

PKD 72.10.Z - MAZOWIECKIE

Voivodeship

MAZOWIECKIE

29 companies in PKD in this voivodeship

Companies in PKD - voivodeship

Companies in PKD - nationwide

Voivodeship share of PKD

39.73%

Revenue position

Rank 39 - broader population

Avg. PKD revenue (region)

1.9 M PLN

Median PKD revenue (region)

74.9 K PLN

Geographic concentration of PKD

Leading voivodeship: MAZOWIECKIE (39.73%)
Top 3 voivodeships: MAZOWIECKIE, ŚLĄSKIE, MAŁOPOLSKIE (69.86%)
Concentration level: Moderate

Voivodeship statistics

Total companies: 353,593
Companies with financial data: 106,388
Companies in PKD in the region: 29